These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 30226107)

  • 61. Ligand binding and functional selectivity of L-tryptophan metabolites at the mouse aryl hydrocarbon receptor (mAhR).
    Nuti R; Gargaro M; Matino D; Dolciami D; Grohmann U; Puccetti P; Fallarino F; Macchiarulo A
    J Chem Inf Model; 2014 Dec; 54(12):3373-83. PubMed ID: 25402742
    [TBL] [Abstract][Full Text] [Related]  

  • 62.
    Kallimanis P; Chinou I; Panagiotopoulou A; Soshilov AA; He G; Denison MS; Magiatis P
    Molecules; 2022 Apr; 27(8):. PubMed ID: 35458697
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The Aryl Hydrocarbon Receptor Ligand 6-Formylindolo(3,2-b)carbazole Promotes Estrogen Receptor Alpha and c-Fos Protein Degradation and Inhibits MCF-7 Cell Proliferation and Migration.
    Cano-Sánchez J; Murillo-González FE; de Jesús-Aguilar J; Cabañas-Cortés MA; Tirado-Garibay AC; Elizondo G
    Pharmacology; 2023; 108(2):157-165. PubMed ID: 36657432
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Specific ligand binding domain residues confer low dioxin responsiveness to AHR1β of Xenopus laevis.
    Odio C; Holzman SA; Denison MS; Fraccalvieri D; Bonati L; Franks DG; Hahn ME; Powell WH
    Biochemistry; 2013 Mar; 52(10):1746-54. PubMed ID: 23394719
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Implications of tryptophan photoproduct FICZ in oxidative stress and terminal differentiation of keratinocytes.
    Furue M; Uchi H; Mitoma C; Hashimoto-Hachiya A; Tanaka Y; Ito T; Tsuji G
    G Ital Dermatol Venereol; 2019 Feb; 154(1):37-41. PubMed ID: 30035475
    [TBL] [Abstract][Full Text] [Related]  

  • 66. A New Insight into the Potential Role of Tryptophan-Derived AhR Ligands in Skin Physiological and Pathological Processes.
    Szelest M; Walczak K; Plech T
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33499346
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Comparative analysis of interactions between aryl hydrocarbon receptor ligand binding domain with its ligands: a computational study.
    Chitrala KN; Yang X; Nagarkatti P; Nagarkatti M
    BMC Struct Biol; 2018 Dec; 18(1):15. PubMed ID: 30522477
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Editor's Highlight: Ah Receptor Activation Potentiates Neutrophil Chemoattractant (C-X-C Motif) Ligand 5 Expression in Keratinocytes and Skin.
    Smith KJ; Boyer JA; Muku GE; Murray IA; Gowda K; Desai D; Amin SG; Glick AB; Perdew GH
    Toxicol Sci; 2017 Nov; 160(1):83-94. PubMed ID: 28973351
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Jasmone Is a Ligand-Selective Allosteric Antagonist of Aryl Hydrocarbon Receptor (AhR).
    Vrzal R; Marcalíková A; Krasulová K; Zemánková L; Dvořák Z
    Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958638
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The Ability of AhR Ligands to Attenuate Delayed Type Hypersensitivity Reaction Is Associated With Alterations in the Gut Microbiota.
    Abdulla OA; Neamah W; Sultan M; Alghetaa HK; Singh N; Busbee PB; Nagarkatti M; Nagarkatti P
    Front Immunol; 2021; 12():684727. PubMed ID: 34267755
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The Effects of Astaxanthin on Proliferation and Differentiation of MG-63 Osteosarcoma Cells via Aryl Hydrocarbon Receptor (AhR) Pathway: A Comparison with AhR Endogenous Ligand.
    Montazeri-Najafabady N; Dabbaghmanesh MH; Chatrabnous N; Arabnezhad MR
    Nutr Cancer; 2020; 72(8):1400-1410. PubMed ID: 31847600
    [No Abstract]   [Full Text] [Related]  

  • 72. Light Sensing beyond Vision: Focusing on a Possible Role for the FICZ/AhR Complex in Skin Optotransduction.
    Guarnieri T
    Cells; 2024 Jun; 13(13):. PubMed ID: 38994936
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Smad7 Knockdown Restores Aryl Hydrocarbon Receptor-mediated Protective Signals in the Gut.
    Monteleone I; Marafini I; Zorzi F; Di Fusco D; Dinallo V; Rizzo A; Sileri P; Sica G; Monteleone G
    J Crohns Colitis; 2016 Jun; 10(6):670-7. PubMed ID: 26818761
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The aryl hydrocarbon receptor in immunity.
    Esser C; Rannug A; Stockinger B
    Trends Immunol; 2009 Sep; 30(9):447-54. PubMed ID: 19699679
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Aryl hydrocarbon receptor agonists trigger avoidance of novel food in rats.
    Mahiout S; Pohjanvirta R
    Physiol Behav; 2016 Dec; 167():49-59. PubMed ID: 27594096
    [TBL] [Abstract][Full Text] [Related]  

  • 76. From TCDD-mediated toxicity to searches of physiologic AHR functions.
    Bock KW
    Biochem Pharmacol; 2018 Sep; 155():419-424. PubMed ID: 30055148
    [TBL] [Abstract][Full Text] [Related]  

  • 77.
    Yamada T; Takaoka A
    Bio Protoc; 2017 Jan; 7(1):e2097. PubMed ID: 34458427
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The human Ah receptor: hints from dioxin toxicities to deregulated target genes and physiological functions.
    Bock KW
    Biol Chem; 2013 Jun; 394(6):729-39. PubMed ID: 23370907
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Aryl hydrocarbon receptor signaling modulates antiviral immune responses: ligand metabolism rather than chemical source is the stronger predictor of outcome.
    Boule LA; Burke CG; Jin GB; Lawrence BP
    Sci Rep; 2018 Jan; 8(1):1826. PubMed ID: 29379138
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Suppression of CYP1 members of the AHR response by pathogen-associated molecular patterns.
    Peres AG; Zamboni R; King IL; Madrenas J
    J Leukoc Biol; 2017 Dec; 102(6):1471-1480. PubMed ID: 29018148
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.